The living layer
The Pulse
Longevity moves fast and loose; this feed moves with the evidence instead. Briefs when a trial reports, checks when a claim goes viral, notes when a grade changes — every post anchored to the studies themselves.
- Hype check
The taurine reversal, explained
In 2023 taurine was a Science-paper sensation. In 2025 a large human analysis reported evidence against its central premise. What actually happened, and what it teaches about longevity headlines.
- Evidence brief
The biggest longevity trials ever run were null — and almost nobody talks about them
D-Health randomised 21,315 people to vitamin D. VITAL randomised 25,871 to fish oil. Both are landmark answers to longevity questions, and both found nothing. Why null results are the field's most underrated information.
- Evidence brief
Rapamycin is longevity's best cautionary tale — because its evidence is genuinely good
Two promising randomised trials, then a failed phase 3 on the same idea. Rapamycin shows what 'mixed evidence' really means — and why early trial success is not a purchase signal.
- Hype check
16:8 fasting met its best test — and lost
Time-restricted eating is the most practised longevity intervention in the world. The TREAT randomised trial tested its most repeated claim, effortless weight loss, and found no benefit over eating normally.
- Site notes
Why our grades will change — and why that is the feature
Longevity Record's evidence grades are computed from recorded study facts by a fixed public rubric. When a new trial reports, the grade moves. Here is how that works and why we built it that way.
Get the next one by email
The newsletter is these posts, delivered — nothing more.
Join the newsletter